Exagen Inc. (XGN) Free Cash Flow
Exagen Inc. (XGN) free cash flow history and trends. Track FCF in Excel with MarketXLS.
Free Cash Flow Data
| Period | Free Cash Flow (USD) |
|---|---|
| 2019-12-31 | -$9.81M |
| 2020-12-31 | -$14.54M |
| 2021-12-31 | -$22.64M |
| 2022-12-31 | -$36.46M |
| 2023-12-31 | -$15.29M |
| 2024-12-31 | -$13.79M |
| 2025-12-31 | -$14.27M |
How XGN compares with sector peers
| Symbol | Company | Free cash flow (latest fiscal year) |
|---|---|---|
| RFL | Rafael Holdings Inc. Class B | -$18.95M |
| STIM | Neuronetics Inc. | -$21.18M |
| NEO | NeoGenomics Inc. | -$21.78M |
| DMAC | DiaMedica Therapeutics Inc. | -$29.10M |
| ATOS | Atossa Therapeutics Inc. | -$29.79M |
These are five companies in the same sector as XGN with a comparable annual free cash flow. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Exagen Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Free_Cash_Flow("XGN", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | XGN | $7.39 | -1.73% | 0.24M |
| 3 | ||||
| 4 | ||||
| 5 |